英文药名：Aloxi i.v. injection（Palonosetron Hydrochloride） 中文药名：盐酸帕洛诺司琼注射剂/点滴静注 适应证：预防化疗诱发的呕吐及手术后的恶心和呕吐。 生产厂家：大鵬薬品 アロキシ静注0.75mg／アロキシ点滴静注バッグ0.75mg 治疗类别名称 5-HT3受体拮抗剂的止吐药 商標名 Aloxi I. V. injection 0.75mg Aloxi I. V. infusion bag 0.75mg 構造式 一般名 パロノセトロン塩酸塩（Palonosetron Hydrochloride） 化学名 （3aS）-2-（[3S-Quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro- 1H-benzo[de]isoquinolin-1-one monohydrochloride 分子式 C19H24N2O・HCl 分子量 332.87 性状 是一种白色或类白色结晶性粉末。非常易溶于水，容易微溶于甲醇和氯仿，乙醇（99.5）微溶。 袋配方： （1）为了保持产品的质量，外袋包围该药物不应该打开直到使用。另外，开封后立即使用。 （2）不应当在未来的情况下使用。 1）当液滴观察并在里面当外袋破损 2）内容液是有色或混浊 （3）在容器的液体比例是被用作粗略指导。 （4）注射针头扎直东西○橡胶塞的标志。通过在容器颈部角刺注射针，可以是泄漏的原因。 （5）在原则上它不能被使用的连接管的串联系统施用。 适应病症 抗肿瘤药（顺铂等），管理（恶心，呕吐）有关的胃肠道症状（包括延迟期） 用法用量 成年人：每天Kaiseichu或静脉滴注为0.75mg。 包装规格 静注 0.75mg：5毫升×5瓶 静脉滴注袋 0.75mg：50ml×5袋 制造厂商 大鹏药业有限公司 完整处方资料附件：http://www.info.pmda.go.jp/go/pack/2391404A1020_1_05/ Aloxi i.v. injection（Palonosetron Hydrochloride） Aloxi i.v. injection 0.75mg（アロキシ静注0.75mg） Brand name : Aloxi i.v. injection 0.75mg 　Active ingredient: Palonosetron Hydrochloride 　Dosage form: injection 　Print on wrapping: Aloxi I.V. infusion bag 0.75mg（アロキシ点滴静注バッグ0.75mg）  Brand name : Aloxi I.V. infusion bag 0.75mg 　Active ingredient: Palonosetron Hydrochloride 　Dosage form: injection 　Print on wrapping: Effects of this medicine This medicine is used to prevent chemotherapy-induced nausea and vomiting. It is usually used for the treatment of gastrointestinal symptom (nausea, vomiting) caused by anti-cancer medicines. Before using this medicine, be sure to tell your doctor and pharmacist •If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines. If you have constipation, abdominal pain or abdominal distension. If you are a patient on sodium-restricted diet. •If you are pregnant or breastfeeding. •If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.) Dosing schedule (How to take this medicine) •Your dosing schedule prescribed by your doctor is <<to be written by a healthcare professional>> •Generally, this medicine is given once daily by intravenous drip infusion. •This medicine is given during the period of administration of anti-cancer medications which cause nausea and vomiting. Ask your doctor for more information. Precautions while taking this medicine • Possible adverse reactions to this medicine The most commonly reported adverse reactions include constipation, headache and vascular pain. If any of these symptoms occur, consult with your doctor or pharmacist. The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately. •itching, erythema (skin redness), difficulty breathing [shock, anaphylaxis] The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above. TAIHO Pharmaceutical Co.,LTD.Injection Published: 10/2012 The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.